Vanguard Health Care ETF (VHT)
An exchange-traded fund listed on AMEX. A fund is not a company: it has no filed accounts of its own here, and it is never ranked beside companies. Every figure below is market data, with the day it was supplied.
Price
Last close 329.15 USD on Oct 15, 2026. Market data, supplied Oct 15, 2026.
What it costs
| Expense ratio | 0.09% |
| Assets under management | 22.00B USD |
| Net asset value per share | 322.98 USD |
| Inception | Jan 26, 2004 |
| Sponsor | Vanguard |
| Asset class | Sector Equity |
| Holdings the fund reports | 411 |
Market data, supplied Oct 15, 2026.
What it holds
The largest 25 by weight of the 420 holdings in the snapshot of Oct 14, 2026. A fund is marked as a fund, and a holding that is not a company's share (a bond, a bill, cash, an option or a swap) is marked as not a company.
| # | Holding | Weight |
|---|---|---|
| 1 | Eli Lilly & Co | 12.79% |
| 2 | Johnson & Johnson | 8.72% |
| 3 | AbbVie Inc | 6.26% |
| 4 | Merck & Co Inc | 5.04% |
| 5 | UnitedHealth Group Inc | 4.89% |
| 6 | Amgen Inc | 3.21% |
| 7 | Thermo Fisher Scientific Inc | 3.17% |
| 8 | Abbott Laboratories | 2.66% |
| 9 | Gilead Sciences Inc | 2.51% |
| 10 | Pfizer Inc | 2.24% |
| 11 | Vertex Pharmaceuticals Inc | 1.91% |
| 12 | Bristol-Myers Squibb Co | 1.88% |
| 13 | Danaher Corp | 1.88% |
| 14 | Intuitive Surgical Inc | 1.84% |
| 15 | CVS Health Corp | 1.66% |
| 16 | Medtronic PLC | 1.60% |
| 17 | Stryker Corp | 1.54% |
| 18 | McKesson Corp | 1.43% |
| 19 | Elevance Health Inc | 1.14% |
| 20 | Regeneron Pharmaceuticals Inc | 1.14% |
| 21 | Cigna Group/The | 1.01% |
| 22 | Boston Scientific Corp | 0.99% |
| 23 | HCA Healthcare Inc | 0.89% |
| 24 | Cencora Inc | 0.83% |
| 25 | Cardinal Health Inc | 0.76% |
Market data, supplied Oct 15, 2026.
Sector weights
| Healthcare | 99.95% |
| Financial Services | 0.03% |
| Industrials | 0.01% |
| Technology | 0.01% |
Market data, supplied Oct 15, 2026.
Country weights
| United States | 100.00% |
| Other | 0.00% |
Market data, supplied Oct 15, 2026.
Look-through value
Earnings yield, P/E and book yield of the holdings taken together: n/a. Look-through figures are not measured for this fund yet.